Pharma Mar SA
PHM
Real-time TRADEGATE AG - 01/17 01:25:02 pm
1.275EUR
-2.95%
Prev.1.3140
Open1.3120
High1.3220
Low1.2630
Volume834 030
Financials
Sales 2018 167 M
EBIT 2018 -7,50 M
R. net 2018 -7,47 M
Debt 2018 98,6 M
Rend. 2018 -
P/E ratio 2018 -
P/E ratio 2019 18,77
EV / Sales 2018 2,35x
EV / Sales 2019 2,73x
Capitalization 293 M
Company
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and...
Sector :
Biopharmaceuticals
Calendar :
2019-02-26 Earnings Release
Trading Rating :
Investor Rating :
Latest news
01/08PHARMA MAR : Liquidity contracts and specialists
PU
2018PHARMA MAR : Phase II trial of lurbinectedin in progressive mesothelioma finalizes its patient recruitment
PU
2018PHARMA MAR : PharmaMar announces the approval of AplidinŽ in Australia for the treatment of multiple myeloma
PU
2018R&D : new licenses, patents and registered trademarks
PU
2018PHARMA MAR : The Spanish Agency of Medicines and Medical Devices gives their approval to PharmaMar's new facilities
PU
2018PHARMA MAR : PharmaMar announces the meeting of its patient recruitment target in the phase II study with lurbinectedin as a single agent in small-cell lung cancer
PU
2018R&D : new licenses, patents and registered trademarks
PU
2018PHARMA MAR : PharmaMar presents a new Antibody Drug Conjugate at the World ADC Congress in San Diego
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance1,441,711,81
Spread/Res.-12%-26%-30%
Spread/Supp.2,7%38%38%
Support1,240,920,92